Cosmo Pharmaceuticals

Cosmo Pharmaceuticals S.p.A. is a specialty pharmaceutical company that produces generic products and specialized drugs for the treatment of gastrointestinal diseases. The company's proprietary clinical development pipeline focuses specifically on innovative treatments for inflammatory bowel diseases such as ulcerative colitis, Crohn's disease, and colonic infections. Its products include Zacol NMX, a nutritional product for treating colon diseases; Lialda/Mezavant, used to treat patients with mild to moderate ulcerative colitis. The company’s clinical development products include Budesonide MMX, a Phase III clinical trial product for inducing remission in patients with mild to moderate ulcerative colitis.